R&D Expenses

$25.00M

Quarterly · Period ending: Jun 30, 2026 · USD

MYGN R&D Expenses

Latest reported$25.00Mperiod endingJun 30, 2026

MYGN Quarterly R&D Expenses ($0.00 → $25.00M)

Quarterly R&D Expenses

High-resolution chart · PNG

MYGN r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2026	25,000,000
Mar 31, 2026	27,100,000
Dec 31, 2025	25,500,000
Sep 30, 2025	28,200,000
Jun 30, 2025	25,600,000
Mar 31, 2025	27,500,000
Dec 31, 2024	32,200,000
Sep 30, 2024	28,500,000
Jun 30, 2024	27,100,000
Mar 31, 2024	24,900,000
Dec 31, 2023	21,000,000
Sep 30, 2023	24,000,000
Jun 30, 2023	21,200,000
Mar 31, 2023	22,500,000
Dec 31, 2022	23,400,000
Sep 30, 2022	20,500,000
Jun 30, 2022	20,300,000
Mar 31, 2022	21,200,000
Dec 31, 2021	20,500,000
Sep 30, 2021	18,800,000
Jun 30, 2021	19,500,000
Mar 31, 2021	23,100,000
Dec 31, 2020	0
Sep 30, 2020	17,600,000
Jun 30, 2020	17,400,000
Mar 31, 2020	19,700,000
Dec 31, 2019	18,800,000
Sep 30, 2019	21,300,000
Jun 30, 2019	20,900,000
Mar 31, 2019	21,500,000
Dec 31, 2018	22,400,000
Sep 30, 2018	21,100,000
Jun 30, 2018	17,700,000
Mar 31, 2018	18,500,000
Dec 31, 2017	16,800,000
Sep 30, 2017	17,800,000
Jun 30, 2017	18,800,000
Mar 31, 2017	17,600,000
Dec 31, 2016	18,600,000
Sep 30, 2016	19,400,000
Jun 30, 2016	19,500,000
Mar 31, 2016	17,200,000
Dec 31, 2015	16,700,000
Sep 30, 2015	17,200,000
Jun 30, 2015	18,700,000
Mar 31, 2015	16,673,000
Dec 31, 2014	17,504,000
Sep 30, 2014	22,612,000
Jun 30, 2014	20,187,000
Mar 31, 2014	13,397,000
Dec 31, 2013	17,090,000
Sep 30, 2013	16,803,000
Jun 30, 2013	14,581,000
Mar 31, 2013	13,618,000
Dec 31, 2012	14,107,000
Sep 30, 2012	11,400,000
Jun 30, 2012	12,144,000
Mar 31, 2012	11,753,000
Dec 31, 2011	10,243,000
Sep 30, 2011	8,505,000
Jun 30, 2011	9,231,000
Mar 31, 2011	6,667,000
Dec 31, 2010	6,092,000
Sep 30, 2010	5,762,000
Jun 30, 2010	5,253,000
Mar 31, 2010	5,885,000
Dec 31, 2009	5,059,000
Sep 30, 2009	5,676,000
Jun 30, 2009	-37,036,000
Mar 31, 2009	17,850,000
Dec 31, 2008	19,952,000
Sep 30, 2008	17,149,000
Jun 30, 2008	55,225,000
Mar 31, 2008	31,161,000
Dec 31, 2007	27,306,000
Sep 30, 2007	26,025,000
Jun 30, 2007	26,175,000
Mar 31, 2007	23,418,000
Dec 31, 2006	24,764,000
Sep 30, 2006	26,352,000
Jun 30, 2006	24,294,000
Mar 31, 2006	21,967,000
Dec 31, 2005	19,030,000
Sep 30, 2005	18,466,000
Jun 30, 2005	16,025,000
Mar 31, 2005	15,540,000
Dec 31, 2004	14,546,000
Sep 30, 2004	13,132,000
Jun 30, 2004	12,004,000
Mar 31, 2004	12,390,000
Dec 31, 2003	11,558,000
Sep 30, 2003	12,974,000
Jun 30, 2003	13,372,000
Mar 31, 2003	11,053,000
Dec 31, 2002	12,218,000
Sep 30, 2002	10,946,000
Jun 30, 2002	10,680,968
Mar 31, 2002	8,739,952
Dec 31, 2001	8,612,388
Sep 30, 2001	8,261,360